IN BRIEF PCV13 for Adults ≥65 Years Old

被引：0
|
作者：
不详
机构：
来源：
MEDICAL LETTER ON DRUGS AND THERAPEUTICS | 2014年 / 56卷 / 1453期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：102 / 102
页数：1
相关论文
共 50 条
  • [1] Physician survey regarding updated PCV13 vaccine recommendations for adults ≥65 years
    Hurley, Laura P.
    O'Leary, Sean T.
    Kobayashi, Miwako
    Crane, Lori A.
    Cataldi, Jessica
    Brtnikova, Michaela
    Beaty, Brenda L.
    Gorman, Carol
    Lindley, Megan C.
    Kempe, Allison
    [J]. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2021, 69 (09) : 2612 - 2618
  • [2] PCV13 vaccination for older adults: Another view
    Fedson, David S.
    [J]. VACCINE, 2016, 34 (38) : 4466 - 4466
  • [3] COST-UTILITY ANALYSIS OF PCV13 VERSUS PPSV23 IN ADULTS 65 AND MORE
    Biagini Leandro, L.
    Rojas Ruben, R.
    Fuentealba Francisca, F.
    Pezzani Marcela, M.
    [J]. VALUE IN HEALTH, 2015, 18 (07) : A806 - A806
  • [4] High effectiveness of PCV13 Vaccine to Prevent Community-Acquired Pneumonia in Adults over 65
    Lopardo, G. D.
    Vizzotti, C.
    Giglio, N.
    Raimondo, E.
    Fridman, D.
    Micone, P.
    Gonzalez, M.
    Stamboulian, D.
    [J]. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2018, 73 : 354 - 355
  • [5] Cost-effectiveness of PCV13 vaccination in Belgian adults aged 65-84 years at elevated risk of pneumococcal infection
    Marbaix, Sophie
    Peetermans, Willy E.
    Verhaegen, Jan
    Annemans, Lieven
    Sato, Reiko
    Mignon, Annick
    Atwood, Mark
    Weycker, Derek
    [J]. PLOS ONE, 2018, 13 (07):
  • [6] Comparison of pneumococcal immunogenicity elicited by the PCV13 and PCV15 vaccines in adults 18 through 49 years of age
    Kanevsky, Isis
    Surendran, Naveen
    McElwee, Kathleen
    Lei, Lanyu
    Watson, Wendy
    Pride, Michael
    Scully, Ingrid
    Karauzum, Hatice
    Anderson, Annaliesa
    Young, Mariano
    [J]. VACCINE, 2023, 41 (45) : 6625 - 6629
  • [7] COST/UTILITY ANALYSIS OF PNEUMOCOCCAL VACCINES PCV13 VERSUS PPSV23 IN ADULTS OVER 18 YEARS OLD IN CHILE
    Biagini Leandro, L.
    Rojas Ruben, R.
    Fuentealba Francisca, F.
    Pezzani Marcela, M.
    [J]. VALUE IN HEALTH, 2015, 18 (03) : A240 - A241
  • [8] COST EFFECTIVENESS OF PCV13 VS PPSV23 FOR THE IMMUNIZATION OF ADULTS OVER 65 YEARS WITH LOW OR MODERATE RISK OF PNEUMOCOCCAL INFECTION
    Baez-Revueltas, F. B.
    Laredo, F.
    [J]. VALUE IN HEALTH, 2017, 20 (09) : A931 - A931
  • [9] Identifying missed opportunities for the pneumococcal conjugate vaccine (PCV13) in outpatient Veterans 65 years and older.
    Jindracek, Lauren
    Stark, Jennifer
    Nelson, Jean
    [J]. PHARMACOTHERAPY, 2016, 36 (07): : E117 - E117
  • [10] PCV13 Found to Be as Safe as PCV7
    Cox, Amber
    Zacharyczuk, Colleen
    [J]. PEDIATRIC ANNALS, 2013, 42 (07): : 263 - 263
12345